Benitec Biopharma Competitors and Similar CompaniesClear all

Benitec Biopharma's competitors and similar companies include Resverlogix, Lexicon Pharmaceuticals and Microbiotix.

	Benitec Biopharma Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy.	Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.	Microbiotix Microbiotix is a biopharmaceutical company developing small molecule drugs targeting infectious diseases and multi-drug resistant pathogens.
Founding Date	Founding Date 2001	Founding Date 2001	Founding Date 1995	Founding Date N/A
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Hayward, US HQ Melbourne, AU Louisville, US	Locations Calgary, CA HQ San Francisco, US	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more	Locations Worcester, US HQ
Employees	Employees 14	Employees 19	Employees 20216% increase	Employees 18
Valuation ($)	Valuation ($) 192 m	Valuation ($) 12.9 m	Valuation ($) 737.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $49.8m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $274k (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $50k (FY, 2025)	Gross profit $49.5m (FY, 2025)	Gross profit N/A
Net income	Net income ($37.9m) (FY, 2025)	Net income ($7.8m) (FY, 2025)	Net income ($50.3m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 36.3m	Total funding raised $ 10m	Total funding raised $ 244.7m	Total funding raised N/A